Patents Assigned to Ludwig-Maximilians-Universitat
  • Fibroblast growth factor (FGF23) nucleic acids
    Patent number: 7223563
    Abstract: The invention relates to novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosing and treating hypophosphatemic and hyperphosphatemic disorders comprising inhibiting or stimulating, respectively, the biological activity of FGF23 in a patient. The invention also relates to methods of treating osteoporosis, dermatomyositis, and coronary artery disease comprising stimulating the biological activity of FGF23 in a patient.
    Type: Grant
    Filed: July 10, 2001
    Date of Patent: May 29, 2007
    Assignees: Advanced Research and Technology Institute, Ludwig-Maximilians-Universitat Muchen
    Inventors: Michael Econs, Ken White, Tim Matthias Strom, Thomas Meitinger
  • Housing device for head-worn image recording and method for control of the housing device
    Publication number: 20060098087
    Abstract: In a head-mounted recording device (1), it is suggested that rolling movements (17) of the eyes (8) of the user (4) be used in addition to pitching movements (13) and yawing movements (15) for controlling the viewing field of cameras (12). Using the recording device (1), the biological reflexes for stabilizing the environmental image on the retina are employed for the purpose of stabilizing the image recorded by the cameras (12) in a natural way.
    Type: Application
    Filed: November 6, 2003
    Publication date: May 11, 2006
    Applicant: Ludwig-Maximilians-Universitat
    Inventors: Thomas Brandt, Stefan Glasauer, Erich Schneider
  • Novel fibroblast growth factor (FGF23) and methods for use
    Publication number: 20030181379
    Abstract: The invention relates to novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosing and treating hypophosphatemic and hyperphosphatemic disorders comprising inhibiting or stimulating, respectively, the biological activity of FGF23 in a patient. The invention also relates to methods of treating osteoporosis, dermatomyositis, and coronary artery disease comprising stimulating the biological activity of FGF23 in a patient.
    Type: Application
    Filed: March 4, 2003
    Publication date: September 25, 2003
    Applicant: Advanced Research & Technology Institute and Ludwig-Maximilians-Universitat Munchen
    Inventors: Michael Econs, Ken White, Tim Matthias Strom, Thomas Meitinger
  • Novel fibroblast growth factor ( FGF23) and methods for use
    Publication number: 20020156001
    Abstract: The invention relates to novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosing and treating hypophosphatemic and hyperphosphatemic disorders comprising inhibiting or stimulating, respectively, the biological activity of FGF23 in a patient. The invention also relates to methods of treating osteoporosis, dermatomyositis, and coronary artery disease comprising stimulating the biological activity of FGF23 in a patient.
    Type: Application
    Filed: July 10, 2001
    Publication date: October 24, 2002
    Applicant: Advanced Research & Technology Institute and Ludwig-Maximilians-Universitat Munchen
    Inventors: Michael Econs, Ken White, Tim Matthias Strom, Thomas Meitinger